Waterloo Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Buy
3,189
+204
+7% +$103K 0.11% 171
2025
Q4
$1.39M Buy
2,985
+2,014
+207% +$935K 0.1% 174
2025
Q3
$414K Buy
971
+189
+24% +$73.3K 0.03% 315
2025
Q2
$300K Buy
782
+131
+20% +$47.2K 0.02% 351
2025
Q1
$225K Buy
+651
New +$209K 0.02% 363
2024
Q4
Sell
-970
Closed -$394K 372
2024
Q3
$394K Buy
+970
New +$355K 0.04% 276
2024
Q2
Sell
-816
Closed -$272K 363
2024
Q1
$272K Buy
+816
New +$249K 0.03% 300
2023
Q2
Sell
-968
Closed -$255K 229
2023
Q1
$255K Buy
+968
New +$246K 0.08% 153

Other funds holding HCA

Waterloo Capital's HCA Position: Q1 2026 in Review

Waterloo Capital increased its HCA Healthcare (HCA) stake by 6.8% in Q1 2026, buying an estimated $103K and bringing the position to 3,189 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #171.

Waterloo Capital first reported a position in HCA in Q1 2023 and has held it in 8 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Waterloo Capital held 3,189 shares of HCA Healthcare worth $1.51M as of Q1 2026.
  • Waterloo Capital bought 204 HCA Healthcare shares in Q1 2026, an estimated $103K.
  • HCA Healthcare made up 0.11% of Waterloo Capital's portfolio in Q1 2026, its #171 holding.
  • Waterloo Capital first reported a position in HCA Healthcare in Q1 2023 and has held it in 8 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.